Comparison of the new PRC software with the established algorithm of the FMF UK for the detection of trisomy 21 and 18/13

Fetal Diagnosis and Therapy

Volumn 24, Issue 4, 2009, Pages 376-384

  Luthgens K ^a  

^a Laboratory Prof Enders and Partners   (Germany)

Author keywords

ASTRAIA; Free beta hCG; Nuchal translucency; PAPP A; Prenatal risk calculation PRC; Screening for trisomy 21; Trisomy 18 13

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PROTEIN;

ADULT; ALGORITHM; ARTICLE; BODY WEIGHT; CIGARETTE SMOKING; CONTROLLED STUDY; ETHNICITY; FALSE POSITIVE RESULT; FEMALE; HUMAN; MEDICAL INSTRUMENTATION; NON PROFIT ORGANIZATION; NUCHAL TRANSLUCENCY MEASUREMENT; PRENATAL RISK CALCULATION SOFTWARE; PRENATAL SCREENING; PRIORITY JOURNAL; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ADULT; ALGORITHMS; BODY WEIGHT; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; EUROPEAN CONTINENTAL ANCESTRY GROUP; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; REPRODUCIBILITY OF RESULTS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SMOKING; SOFTWARE; TRISOMY;

EID: 54149110963     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000165116     Document Type: Article

References (18)

1. Nicolaides KH: Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004;191:45-67.
2. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O: Multicenter study of first-trimester screening for trisomy 21 in 75,821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005;25:221-226.
3. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH: UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998;351:343-346.
4. Eiben B, Thode C, Glaubitz R: Das neue Ersttrimesterscreening-Programm PRC der FMF-Deutschland: erste Erfahrungen zur Trisomie-21-Entdeckungsrate. Frauenarzt 2007;48:2-4.
5. Eiben B, Glaubitz R, Thode C: Das Ersttrimesterscreening mit dem neuen Prenatal-Risk-Calculation(PRC)-Programm. Gyne 2007;28:117-125.
6. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristics curves: a nonparametric approach. Biometrics 1988;44:837-845.
7. Spencer K: Accuracy of Down syndrome risks produced in a first trimester screening programme incorporating fetal nuchal translucency thickness and maternal serum biochemistry. Prenat Diagn 2002;22:244-246.
8. Spencer K: Aneuploidy screening in the first trimester. Am J Med Genet C Semin Med Genet 2007;145C:18-32.
9. Malone FD, Canick JA, Ball RH, Nyberg DA, et al: First-trimester or second-trimester screening, or both, for Down's syndrome. NEJM 2005;353:2001-2011.
10. Kozlowski P, Knippel AJ, Stressig R: Comparing first trimester screening performance: routine care gynaecologists' practices vs. prenatal centre. Ultraschall Med 2007;28:291-295.
11. Nix B, Wright D, Baker A: The impact of bias in MoM values on patient risk and screening performance for Down syndrome. Prenat Diagn 2007;27:840-845.
12. Reynolds TM, Vranken G, Van Nueten J: Weight correction of MoM values: which method? J Clin Pathol 2006;59:753-758.
13. Krantz DA, Hallahan TW, Macri VJ, Macri JN: Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program. Prenat Diagn 2005;25:635-640.
14. Spencer K, Bindra R, Nicolaides KH: Maternal weight correction of maternal serum PAPP-A and free beta-hCG MoM when screening for trisomy 21 in the first trimester of pregnancy. Prenat Diagn 2003;23:851-855.
15. Spencer K, Heath V, El-Sheikhah A, Ong CY, Nicolaides KH: Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 2005;25:365-369.
16. Spencer K, Bindra R, Cacho AM, Nicolaides KH: The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 2004;24:169-173.
17. Niemimaa M, Heinonen S, Seppälä M, Ryynänen M: The influence of smoking on the pregnancy-associated plasma protein A, free beta human chorionic gonadotrophin and nuchal translucency. BJOG 2003;110:664-667.
18. Kagan KO, Frisova V, Nicolaides KH, Spencer K: Dose dependency between cigarette consumption and reduced maternal serum PAPP-A levels at 11-13 + 6 weeks of gestation. Prenat Diagn 2007;27:849-853.